Medical device surface finishing options fall into two broad families: processes that remove or modify material at the surface, and coatings that add a functional layer. Electropolishing, passivation, pickling, abrasive blasting and burnishing change the substrate itself. Coating platforms such as PTFE-based lubricants, hydrophilic films, parylene, ceramic or silicone systems add a distinct layer with its own thickness, cure temperature and adhesion requirements. The appropriate choice depends first on the substrate, then on the required function: low friction, release, dielectric protection, wear resistance, corrosion resistance, controlled roughness or osseointegration. Vendor comparison tables can narrow the field, but they do not replace process validation. A finishing decision should be treated as a manufacturing and biological safety decision, not a catalog selection.
Subtractive Finishing: Electropolishing, Passivation and Blasting
Electropolishing is an electrochemical process that removes material from the device surface, with greater removal from peaks in the surface profile, thereby reducing roughness [5]. Norman Noble describes the process as useful for removing stress risers, rounding corners, deburring, removing heat-affected zones and micro-cracks, and often improving fatigue life [3]. The same source notes that electropolishing can also be modified to sharpen edges and points, which matters for cutting instruments where a uniform bright finish is not the only objective [3].
A 2026 retrospective analysis in Frontiers in Medical Technology examined chemical characterization data for metallic orthopedic devices and concluded that electropolishing operations effectively remove residues originating from upstream manufacturing materials [5]. The authors propose that electropolishing can serve as a surface reset point in biological safety evaluations, potentially reducing testing requirements, including animal testing, within the ISO 10993 framework [5]. That conclusion is specific to the reviewed extractables data and does not establish that electropolishing alone satisfies all biological evaluation requirements for every device.
Passivation and blasting address different problems. Norman Noble's automated passivation line uses a nine-tank system with pre-cleaning, passivation tanks and recipe-based processing to improve consistency and reduce environmental costs compared with manually controlled systems [3]. Abrasive blasting propels graded media through a nozzle to create matte, rough or bright textures, remove oxides and round corners, while bead blasting lightly peens or cold works the surface with graded beads [3]. Burnishing removes little material, typically only a few ten-thousandths of an inch from corners, and does not remove heat-affected zones; passivation is recommended afterward to remove loose iron [3].
Coating Platforms: Lubricity, Release and Barrier Functions
Integer Medical Coatings organizes its medical coating technologies into six platforms: GlideLine for dry lubricity and mold or mandrel release, HYDAK hydrophilic coatings for wet lubricity during insertion and trackability, VSi Parylene for thin conformal barrier or dielectric protection, IonGuard for wear and galling resistance, MICRALOX for corrosion and abrasion resistance with color identification, and Surface Texturing for osseointegration or controlled roughness [1]. Integer states that nearly all of its medical coating technologies are PFAS-free by design [1]. The company's comparison table rates each platform from 1 to 10 on criteria including dry lubricity, wet lubricity, dielectric strength, mold release, durability, corrosion resistance and substrate breadth, based on internal testing, usage and knowledge [1].
Surface Solutions Group lists 13 medical coating systems with different basic chemistries, operating temperatures, thickness ranges and substrate compatibility [4]. GlideMed is described as a no-PTFE, no-PFAS, water-based coating with a 350°F operating temperature and a thickness range of .0001 to .001 inch, compatible with all metals and nitinol [2]. FluoroMed ZP4 is a PTFE water-based coating with a 500°F operating temperature and a thickness range of .0001 to .0006 inch, but it is not listed as nitinol compatible [2]. MediSlick N2 and N2A are ceramic solvent-based coatings with a 500°F operating temperature and ultra-thin films from .00001 to .0002 inch, compatible with all metals and some rubbers [2].
Documenting the Decision Before Selecting a Finish
A defensible selection record should list the substrate and alloy, the required surface function, the acceptable dimensional change, the sterilization method, and the biological evaluation endpoints. For subtractive processes, record whether the process removes heat-affected zones or only smooths corners; Norman Noble states that burnishing does not remove heat-affected zones, while electropolishing can [3]. For coatings, record the operating temperature, thickness range and substrate compatibility from the vendor's technical sheet, then verify those values on the actual part geometry [2]. If the device is nitinol, confirm low cure temperature compatibility and assess the resulting oxide layer composition [7]. Finally, separate vendor biocompatibility statements from design-owner compliance obligations under ISO 10993-5 [2].
Nitinol-Specific Decisions and the Oxide Layer
Nitinol finishing requires attention to the surface oxide layer. A 2022 review in the Journal of Biomedical Materials Research Part B describes the goal as a stable oxide layer composed of only titanium dioxide with negligible nickel species [7]. The review examines mechanical polishing, electropolishing, magnetoelectropolishing, heat treatments, passivation, chemical etching, boiling in water, hydrogen peroxide treatment and sterilization techniques, and how each affects corrosion resistance [7]. The authors provide a checklist to assist with choosing finishing and sterilization methods for nitinol used in implantable medical devices [7].
Low cure temperature is a practical constraint for nitinol because elevated temperatures can alter the alloy's transformation behavior. Surface Solutions Group's coating list identifies which systems are nitinol compatible at low cure temperature [2]. GlideMed, MediSlick N3 and AquaGlide are marked as nitinol compatible, while FluoroMed ZP4, FluoroMed BL2, FluoroBond N and ElectroBond are not [2]. Slick Sil LSR is listed with a substrate of silicone and rubber and its nitinol compatibility is marked N/A [2]. This distinction is documented by the vendor and should be verified for the specific device geometry and thermal history. The review authors are employees of Abbott, and the checklist reflects their literature synthesis rather than independent regulatory guidance [7].
Regulatory Documentation and Evidence Limits
FDA's draft guidance on characterization of metallic and calcium phosphate coatings on orthopedic devices applies to class II and class III devices with coatings manufactured by thermal spray, sintering, chemical vapor deposition, physical vapor deposition, additive manufacturing or other methods [6]. The draft guidance does not address device-specific functional testing such as system component fatigue testing, and it does not discuss drug or biologic characterization [6]. The document was issued on January 23, 2024, and when finalized will supersede earlier guidance on hydroxyapatite coated implants and metallic plasma sprayed coatings [6].
Biocompatibility claims require careful reading. Surface Solutions Group states that all coatings on its medical grade chart are biocompatible, PFOA-free and PFOS-free, and that biocompatibility is tested to ISO 10993-5 by third-party labs for informational purposes only [2]. The company states that compliance to ISO 10993-5 is the sole responsibility of the design owners [2]. The same disclaimer appears on the MediSlick technical sheet, which also notes that end use conditions beyond the applicator's control may modify results and that users should test suitability for each specific use [8]. These statements limit the evidentiary weight of vendor biocompatibility language.
A Suggested Evaluation Workflow for a Hypothetical Mandrel
Consider a catheter-forming mandrel as a concrete example. The functional requirement is release: the mandrel must separate cleanly from the catheter lumen without leaving residue or changing the lumen diameter. Integer's GlideLine platform is positioned for dry lubricity and mold or mandrel release on guidewires, hypotubes, needles, mandrels, shafts and metal instruments [1]. Surface Solutions Group's MediSlick N2 is described as an ultra-thin PFAS-free coating for smooth cutting surfaces such as scalpels, blades and mandrels, with a film build of 150 to 200 nanometers [8].
The MediSlick technical sheet states that the ultra-thin film eliminates the need to grind mandrels to compensate for thicker traditional PTFE coatings, allowing designers to size the mandrel directly to the tube's inner diameter requirement [8]. It also states that the coating can be reapplied without grit blasting, which alters mandrel diameter and shortens useful life [8]. These are vendor claims about a specific product family. A manufacturer would still need to verify release force, coating adhesion after repeated autoclave or ethylene oxide cycles, and extractables for the finished device. The choice between a dry lubricity platform and an ultra-thin ceramic coating would depend on the catheter material, the required lumen tolerance and the sterilization method, none of which can be resolved from the published data sheets alone.
Sources & references
- SOLUTIONS GUIDE · s24.q4cdn.com
- [PDF] Medical Grade Coatings List - Surface Solutions Group · surfacesolutionsgroup.com
- Surface Finishing - Norman Noble, Inc. · nnoble.com
- Medical Device Coatings - PTFE & PFAS-Free Options · surfacesolutionsgroup.com
- Frontiers | Effectiveness of electropolishing step on elimination of upstream manufacturing material residues on metallic orthopaedic medical device · www.frontiersin.org
- Characterization of Metallic Coatings and/or Calcium Phosphate Coatings on Orthopedic Devices · www.fda.gov
- Surface finishing of <fc>N</fc>itinol for implantable medical devices: A review - Mani - 2022 - Journal of Biomedical Materials Research Part B: Applied Biomaterials - Wiley Online Library · onlinelibrary.wiley.com
- MediSlick™ N2/N2A · surfacesolutionsgroup.com